Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Nike
NKE
|
+$631M |
| 2 |
PNC Financial Services
PNC
|
+$614M |
| 3 |
XYZ
Block, Inc.
XYZ
|
+$328M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$275M |
| 5 |
FedEx
FDX
|
+$236M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Meta Platforms (Facebook)
META
|
+$595M |
| 3 |
AbbVie
ABBV
|
+$489M |
| 4 |
Crown Castle
CCI
|
+$326M |
| 5 |
McDonald's
MCD
|
+$325M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 16.57% |
| 3 | Financials | 13.84% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Clorox
CLX
$15.2B
| $32.2M | 0.03% |
242,033
-66,260
| -21% | -$8.82M |
|
327
Cactus
WHD
$2.86B
| $32.1M | 0.03% |
+1,192,640
| New | +$32.1M |
|
|
ZEN
328
DELISTED
ZENDESK INC
ZEN
| $31.7M | 0.03% |
661,829
+7,250
| +1% | +$347K |
|
|
WPZ
329
DELISTED
Williams Partners L.P.
WPZ
| $31M | 0.03% |
899,800
+77,173
| +9% | +$2.66M |
|
|
IMMU
330
DELISTED
Immunomedics Inc
IMMU
| $30.8M | 0.03% |
2,110,377
+279,463
| +15% | +$4.08M |
|
331
Regeneron Pharmaceuticals
REGN
$60.2B
| $30.6M | 0.03% |
88,815
+13,022
| +17% | +$4.48M |
|
332
Fortis
FTS
$24.8B
| $30.4M | 0.03% |
900,532
-952,645
| -51% | -$32.2M |
|
|
VVC
333
DELISTED
Vectren Corporation
VVC
| $30.3M | 0.03% |
+474,527
| New | +$30.3M |
|
334
Duke Energy
DUK
$95B
| $30.3M | 0.03% |
+391,524
| New | +$30.3M |
|
335
BHP
BHP
$138B
| $30.2M | 0.03% |
763,061
-178,961
| -19% | -$7.09M |
|
|
BRKL
336
DELISTED
Brookline Bancorp
BRKL
| $30.2M | 0.03% |
1,863,610
+332,638
| +22% | +$5.39M |
|
|
BOLD
337
DELISTED
Audentes Therapeutics, Inc
BOLD
| $30.1M | 0.03% |
1,002,679
+148,857
| +17% | +$4.47M |
|
338
Thermo Fisher Scientific
TMO
$186B
| $30M | 0.03% |
145,191
-27,021
| -16% | -$5.58M |
|
339
Ameris Bancorp
ABCB
$5.12B
| $29.3M | 0.03% |
553,872
+528,492
| +2,082% | +$28M |
|
|
QVCGA
340
QVC Group, Inc. Series A Common Stock
QVCGA
$87.4M
| $29.3M | 0.03% |
23,975
-288
| -1% | -$352K |
|
341
PPL Corp
PPL
$26.6B
| $29.1M | 0.03% |
1,028,195
-633,002
| -38% | -$17.9M |
|
342
Honeywell
HON
$137B
| $29M | 0.03% |
209,360
-50,901
| -20% | -$7.05M |
|
343
Owens Corning
OC
$13.2B
| $28.9M | 0.03% |
359,815
| – | – |
|
344
Devon Energy
DVN
$22.4B
| $28.6M | 0.03% |
899,942
-95,238
| -10% | -$3.03M |
|
|
GOLD
345
DELISTED
Randgold Resources Ltd
GOLD
| $28.2M | 0.03% |
338,488
-113,447
| -25% | -$9.44M |
|
346
Renasant Corp
RNST
$3.63B
| $28.1M | 0.03% |
659,881
-15,228
| -2% | -$648K |
|
347
Byline Bancorp
BY
$1.33B
| $28M | 0.03% |
1,223,116
+367,530
| +43% | +$8.43M |
|
348
Madrigal Pharmaceuticals
MDGL
$9.79B
| $26.7M | 0.03% |
228,658
+24,458
| +12% | +$2.86M |
|
|
CALD
349
DELISTED
Callidus Software, Inc.
CALD
| $26.5M | 0.03% |
735,945
-235,124
| -24% | -$8.45M |
|
|
AVXS
350
DELISTED
AveXis, Inc. Common Stock
AVXS
| $26.4M | 0.03% |
214,014
+28,920
| +16% | +$3.57M |
|